Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury. A Randomized Clinical Trial

Abstract

There is currently no available drug to prevent the development of post-traumatic epilepsy. insufficient evidence regarding the effect of biperiden in preventing post-traumatic epilepsy after TBI. The combined effect of variables known to have an impact on the likelihood of developing late post-traumatic seizures and its unbalanced frequency in the different groups is an aspect to be considered and underpins the need for larger studies.

Highlights Prior research suggests anticholinergics may prevent post-traumatic epilepsy

There was insufficient evidence on biperiden’s role in preventing PTE after TBI

Variable impact on post-traumatic epilepsy underscores need for broader studies

• Download figure
• Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT01048138

Funding Statement

This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant number 2018/24561-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES; Finance Code 001).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval statement: The study protocol was approved by the Research Ethics Committee of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HC-FMUSP; CAAE n 08533513.6.2002.0068) and Universidade Federal de Sao Paulo (UNIFESP; CAAE n 08533513.6.1001.5505)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes